Corline Biomedical AB (CLBIO.ST) released Loss for fourth quarter of -SEK5.03 million
The company's bottom line totaled -SEK5.03 million, or -SEK0.20 per share. This compares with -SEK14.16 million, or -SEK0.62 per share, last year.
The company's revenue for the period rose 4.6% to SEK2.104 million from SEK2.012 million last year.
Corline Biomedical AB earnings at a glance (GAAP) :
-Earnings: -SEK5.03 Mln. vs. -SEK14.16 Mln. last year.-EPS: -SEK0.20 vs. -SEK0.62 last year.-Revenue: SEK2.104 Mln vs. SEK2.012 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.